The evolution of curative cancer therapy.
Frei
E
E
Department of Medicine, Harvard University School of Medicine, Boston, MA.
D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D002470:Cell Survival / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000401:mortality; D015996:Survival Rate; D014407:Tumor Cells, Cultured / Q000187:drug effects
D000970:Antineoplastic Agents